CGEM

NASDAQStock

Cullinan Therapeutics, Inc.

$13.55-0.40 (-2.87%)

52-Week Range

$5.75

$16.30

Key Stats

Market Cap

800.5M

P/E Ratio

—

Dividend Yield

—

Beta

-0.16

Volume

501.2K

Avg Volume

881.8K

Performance

+19.33%

+28.93%

+119.69%

YTD

+37.85%

+58.70%

+24.44%

-68.92%

Price Chart

ETF Exposure

CGEM is held by 86 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
WDSC.L	State Street SPDR MSCI World Small Cap UCITS ETF (Acc)	0.00%	4,100	$50K	$1.71B	0.45%
WOSC.L	State Street SPDR MSCI World Small Cap UCITS ETF (Acc)	0.00%	4,100	$37K	$1.28B	0.45%
ZPRS.DE	State Street SPDR MSCI World Small Cap UCITS ETF (Acc)	0.00%	4,100	$42K	$1.48B	0.45%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	11,330	$158K	$10.37B	0.12%
AVUS	Avantis U.S. Equity ETF	0.00%	15,101	$156K	$10.96B	0.15%
DFUS	Dimensional - US Equity Market ETF	0.00%	7,488	$104K	$18.51B	0.09%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	69,673	$997K	$80.22B	0.03%
IWV	iShares Russell 3000 ETF	0.00%	16,661	$238K	$17.30B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.00%	29,873	$421K	$37.50B	0.03%
USFM.L	UBS MSCI USA Select Factor Mix UCITS ETF USD dis	0.00%	118	$2K	$134.4M	0.25%
VTHR	Vanguard Russell 3000 ETF	0.00%	4,664	$56K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	1,855,966	$22.2M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	9,762	$158K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	841	$14K	$1.29B	0.17%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	69,673	$78K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	69,673	$24K	$3.91B	0.07%
IMID.L	State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)	0.00%	1,700	$21K	$5.16B	0.17%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	5	$64	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	15	$214	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	26	$365	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	29	$420	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	35	$497	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	29	$414	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	19	$273	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	14	$206	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	6	$91	$9.3M	0.12%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	802	$9K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	802	$9K	$6.3M	0.60%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.00%	322	$4K	$1.43B	0.09%
SPYI.DE	State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)	0.00%	1,700	$18K	$4.48B	0.17%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	802	$9K	$1.0M	0.79%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	91	$1K	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	3,260	$53K	$12.17B	0.24%
VETS	Pacer Military Times Best Employers ETF	0.00%	802	$9K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	802	$9K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	15	$255	$337.7M	0.32%

PreviousPage 2 of 2

About CGEM ETF Exposure

Cullinan Therapeutics, Inc. (CGEM) is held by 86 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 800.5M, CGEM is a widely held institutional stock. The stock currently trades at $13.55. Investors can gain exposure to CGEM through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CGEM, sorted by portfolio weight.